Source: Annual Congress 2005 - Current and emerging anti-inflammatory therapies
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. I. Maassen van den Brink, J. Staal-van den Brekel, M. Boorsma, S. Edsbacker, E. F. Wouters, L. Thorsson (Maastricht, Zoetermeer, Netherlands; Lund, Sweden). Evidence of in vivo esterification of budesonide in humans. Eur Respir J 2005; 26: Suppl. 49, 2389

Member's Comments

No comment yet.

Related content which might interest you: Tissue retention and esterification is greater for budesonide than for ciclesonide in trachea ex vivo Source: Eur Respir J 2004; 24: Suppl. 48, 345s Year: 2004 Esterification prolongs retention of budesonide but not ciclesonide - active principle in rat trachea Source: Eur Respir J 2005; 26: Suppl. 49, 369s Year: 2005 Greater esterification and retention of budesonide in the airways and lung as compared to ciclesonide after repeated intratracheal administration in vivo Source: Eur Respir J 2004; 24: Suppl. 48, 345s Year: 2004 Highly lipophilic fatty acid esters of the active metabolite of ciclesonide formed in vitro in rat lung tissue Source: Eur Respir J 2004; 24: Suppl. 48, 345s Year: 2004 Reversible intracellular esterification increases budesonide airway selectivity Source: Eur Respir J 2001; 18: Suppl. 33, 158s Year: 2001 Pharmacokinetic factors affecting airway selectivity of inhaled steroids - role of intracellular esterification Source: Eur Respir J 2001; 18: Suppl. 33, 147s Year: 2001 Deposition and metabolism of inhaled ciclesonide in the human lung Source: Eur Respir J 2010; 36: 1113-1119 Year: 2010 Budesonide is retained in the airways longer than mometasone furoate due to the reversible formation of lipophilic budesonide fatty acid esters - significance for asthma therapy Source: Eur Respir J 2002; 20: Suppl. 38, 53s Year: 2002 The combination of budesonide and formoterol exerts more rapid and enhanced anti-inflammatory effects than either drug alone in rat lungs in vivo Source: Eur Respir J 2004; 24: Suppl. 48, 344s Year: 2004 Synergistic interaction between beclomethasone diproprionate and formoterol fumarate in an ex vivo model of bronchial asthma Source: International Congress 2018 – Basic pharmacology Year: 2018 Preclinical in vivo assessment of ciclesonide, a novel corticosteroid for the treatment of asthma Source: Eur Respir J 2001; 18: Suppl. 33, 95s Year: 2001 Budesonide esterification in human bronchial epithelial cells is not impaired by formoterol Source: Eur Respir J 2002; 20: Suppl. 38, 619s Year: 2002 In vitro metabolism of ciclesonide, beclomethasone dipropionate, budesonide and fluticasone propionate in human precision-cut lung slices Source: Eur Respir J 2005; 26: Suppl. 49, 255s Year: 2005 Effect of a novel inhaled glucocorticoid, ciclesonide, on an allergen-induced asthmatic response in rats and its prolonged anti-inflammatory activity in vitro Source: Eur Respir J 2002; 20: Suppl. 38, 91s Year: 2002 Pharmacokinetic factors affecting airway selectivity of inhaled steroids – role of prodrug conversion and absorption Source: Eur Respir J 2004; 24: Suppl. 48, 347s Year: 2004 Tissue accumulation kinetics of ciclesonide-active metabolite and budesonide in mice Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD II Year: 2008 In vitro anti-inflammatory activity of the new glucocorticoid ciclesonide in human cells Source: Eur Respir J 2001; 18: Suppl. 33, 95s Year: 2001 Different tissue accumulation kinetics of ciclesonide-active metabolite and budesonide in mice Source: Eur Respir J 2006; 28: Suppl. 50, 433s Year: 2006 Esterases involved in the hydrolysis of ciclesonide in human tissues Source: Eur Respir J 2003; 22: Suppl. 45, 267s Year: 2003 Prolonged activity where it matters - the reversible esterfication of budesonide improves its topical anti-inflammatory efficacy and selectivity in the airways Source: Eur Respir J 2001; 18: Suppl. 33, 21s Year: 2001